Edition:
United States

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

7.69USD
20 Jul 2018
Change (% chg)

$-0.38 (-4.71%)
Prev Close
$8.07
Open
$8.04
Day's High
$8.19
Day's Low
$7.66
Volume
113,361
Avg. Vol
213,572
52-wk High
$9.86
52-wk Low
$1.59

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: 2.73
Market Cap(Mil.): $327.00
Shares Outstanding(Mil.): 40.52
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 29.12 33.34
EPS (TTM): -0.70 -- --
ROI: -52.95 13.60 13.18
ROE: -53.77 15.30 15.09

BRIEF-Marinus Pharmaceuticals Provides Business Update And 2017 Financial Results

* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND 2017 FINANCIAL RESULTS

Mar 06 2018

Earnings vs. Estimates